The pharmaceutical industry is experiencing a paradigm shift as Artificial Intelligence (AI) and Machine Learning (ML) move from theoretical frameworks to core operational drivers. This paper explores the transition from traditional empirical methods to a data-driven "Pharma 4.0" model, emphasizing advancements in drug design, clinical trials, and patient-centric healthcare. By leveraging Deep Learning, Natural Language Processing, and Computer Vision, the industry is poised to achieve significant cost reductions and improved therapeutic precision. This study highlights the imperative of fostering "AI- literate" practitioners to ensure technology acts as a tool for enhanced healing.
Keywords: Artificial Intelligence; Machine Learning; Pharma 4.0; Drug Discovery; Clinical Trials; Pharmacotherapy; Precision Medicine
| 2-5 Days | Initial Quality & Plagiarism Check |
| 25-35 Days |
Peer Review Feedback |
| 45-60 Days | Total article processing time |